Get Your Personalized Supplement StackSupplement Stack Quiz

Anemarrhena Rhizome Extract

Also known as: Anemarrhena asphodeloides Bunge, Zhi Mu, Anemarrhena rhizome, Rhizoma Anemarrhenae, Anemarrhena asphodeloides

Overview

Anemarrhena rhizome extract is derived from the underground stems of *Anemarrhena asphodeloides*, a perennial plant native to East Asia. It has been traditionally used in Traditional Chinese Medicine (TCM) for various conditions, including lung inflammatory disorders, diabetes, and as a general anti-inflammatory and neuroprotective agent. The extract contains several bioactive compounds, with saponins, particularly timosaponin A-III, considered the primary active constituents. Preclinical studies suggest that Anemarrhena rhizome extract possesses anti-inflammatory, neuroprotective, anticancer, and antidiabetic properties. These effects are primarily attributed to the modulation of inflammatory pathways, promotion of neurogenesis, and suppression of cancer stem cell markers. While preclinical evidence is promising, clinical evidence is limited, and large-scale human trials are needed to confirm its efficacy and safety. The extract is available in various forms, including alcoholic and aqueous extracts, with saponin-enriched fractions showing higher activity in some studies.

Benefits

Anemarrhena rhizome extract exhibits several potential benefits, primarily supported by preclinical studies. It demonstrates anti-inflammatory effects by inhibiting NF-κB and pro-inflammatory cytokine production, as shown in animal models of LPS-induced acute lung injury. Aqueous extracts have shown neuroprotective effects by increasing cell proliferation and neuropeptide Y expression in the hippocampus of diabetic rats. Additionally, timosaponin A-III has shown anticancer activity in vitro by inhibiting cancer stem cell phenotype, migration, and invasion. While Anemarrhena is included in TCM formulas for diabetes management, direct evidence for its antidiabetic effects when used alone is limited. Human data is insufficient to draw strong conclusions, and further clinical trials are needed to validate these benefits in humans.

How it works

Anemarrhena rhizome extract exerts its effects through several biological pathways. Its anti-inflammatory action involves the inhibition of NF-κB and the reduction of pro-inflammatory cytokine production. The neuroprotective effects are mediated by the upregulation of neuropeptide Y and the promotion of hippocampal cell proliferation. In cancer cells, it suppresses cancer stem cell markers and inhibits matrix metalloproteinases (MMPs), which are involved in cancer cell invasion and metastasis. The saponins in Anemarrhena, including timosaponin A-III, are believed to be key active components, although their oral bioavailability may be limited. Xanthones, also present in the extract, may contribute to its effects as well. These mechanisms collectively contribute to the observed anti-inflammatory, neuroprotective, and anticancer properties of Anemarrhena rhizome extract.

Side effects

Anemarrhena rhizome extract is generally considered safe based on traditional use and preclinical studies. However, human safety data are limited, and comprehensive clinical trials are needed to fully assess its safety profile. Common, uncommon, and rare side effects have not been reported in the available literature. Potential drug interactions may occur with anti-inflammatory or antidiabetic drugs due to shared pathways, but no specific reports exist. Due to the lack of data, caution is advised during pregnancy and lactation. The safety of Anemarrhena rhizome extract in children, the elderly, and immunocompromised individuals is unknown. It is important to monitor for any adverse reactions when using this supplement and to consult with a healthcare professional, especially if taking other medications or having underlying health conditions.

Dosage

Due to limited human data, the optimal dosage of Anemarrhena rhizome extract is not established. Animal studies have used doses ranging from 50–200 mg/kg of extract or saponin fraction. Traditional TCM formulas use variable amounts of Anemarrhena rhizome. As a general guideline, it is advisable to start with a low dose and gradually increase it while monitoring for any adverse effects. Alcoholic or aqueous extracts are the most studied forms, and saponin-enriched fractions may exhibit higher activity. Saponins may have limited oral bioavailability, so formulation improvements may enhance absorption. Until more data are available, it is prudent to avoid exceeding doses used in preclinical studies scaled to human equivalent doses. Consultation with a healthcare professional is recommended to determine an appropriate and safe dosage.

FAQs

Is Anemarrhena rhizome extract safe?

Animal studies suggest it is relatively safe, but human data are lacking. Caution is advised, especially during pregnancy or lactation. Consult a healthcare provider before use.

How should I take Anemarrhena rhizome extract?

While not specifically studied, taking it with meals may minimize potential gastrointestinal discomfort. Follow product-specific instructions and consult a healthcare professional.

What are the expected benefits of Anemarrhena rhizome extract?

Preclinical data suggest anti-inflammatory and neuroprotective effects, but human efficacy is unproven. Do not consider it a cure-all; more research is needed.

Can Anemarrhena rhizome extract interact with other medications?

Potential interactions with anti-inflammatory or antidiabetic drugs are possible. Consult with a healthcare professional to avoid any adverse effects.

What is the correct dosage of Anemarrhena rhizome extract?

The optimal dosage is not established in humans. Start with a low dose and gradually increase it while monitoring for any adverse effects. Consult a healthcare professional.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC6254648/ – This preclinical animal study found that a saponin-enriched fraction and timosaponin A-III from Anemarrhena rhizome significantly inhibited LPS-induced acute lung injury in mice. The study suggests that these compounds may have potential as anti-inflammatory agents for lung conditions. However, the findings are limited by the use of an animal model and the lack of human data.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7283383/ – This preclinical animal study demonstrated that an aqueous extract of Anemarrhena rhizome increased hippocampal cell proliferation and neuropeptide Y expression in diabetic rats. These findings suggest a potential neuroprotective effect of the extract in the context of diabetes. The study is limited by its small sample size, animal model, and the absence of human data.
https://www.mdpi.com/1422-0067/21/7/2510 – This review discusses the various pharmacological activities of Anemarrhena asphodeloides, highlighting its potential in treating inflammatory diseases, diabetes, and neurological disorders. It emphasizes the importance of its bioactive compounds, such as saponins and xanthones, in mediating these effects. The review calls for more clinical trials to validate these preclinical findings and establish its efficacy and safety in humans.
https://www.e-sciencecentral.org/upload/bt/pdf/bt-26-553.pdf – This study investigates the effects of Anemarrhena asphodeloides on cancer stem cells, finding that timosaponin A-III inhibits cancer stem cell phenotype, migration, and invasion in vitro. The research suggests that timosaponin A-III may have potential as an anticancer agent by targeting cancer stem cells. However, the study is limited to in vitro experiments and requires further validation in vivo and in clinical settings.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1253572/full – This systematic review and meta-analysis examined the effects of Traditional Chinese Medicine (TCM) formulas containing Anemarrhena rhizome on diabetic cardiomyopathy in animal models. The study found that these TCM formulas improved cardiac and metabolic parameters, but the specific contribution of Anemarrhena is unclear due to the complexity of the formulas. The findings are limited by the heterogeneity of the formulas and the lack of human data.